1014482

Paul R. Harmatz, M.D. — FEI 3004936676

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Oakland, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate